Tag Archives: low density lipoprotein cholesterol
February 2011 Br J Cardiol 2011;18:37-45
Efficacy and safety of extended-release niacin/laropiprant in patients with type 2 diabetes mellitus
Alexandra MacLean, James M McKenney, Russell Scott, Eliot Brinton, Harold E Bays, Yale B Mitchel, John F Paolini, Hilde Giezek, Kristel Vandormael, Rae Ann Ruck, Kendra Gibson, Christine McCrary Sisk, Darbie L Maccubbin
An extended version of this paper is available in the downloadable PDFs (see right hand column) to registered users. Registration to the website is free of charge. Introduction Patients with type 2 diabetes mellitus (T2DM) have a two- to four-fold increased risk for cardiovascular disease (CVD) compared with individuals without T2DM.1 A dyslipidaemia pattern of increased levels of triglyceride (TG)-rich particles, and TG enrichment of high- and low-density lipoprotein (HDL and LDL) is common in patients with T2DM, affecting nearly all lipid and lipoprotein variables.2 As a result, dyslipidaemia in patients with T2DM is characterised by el
January 2006 Br J Cardiol 2006;13:72-6
Achieving lipid goals in real life: the DISCOVERY-UK study
Alan Middleton, Ahmet Fuat
No content available
March 2004 Br J Cardiol 2004;11:148-55
Efficacy and safety of fluvastatin ER 80 mg compared with fluvastatin IR 40 mg in the treatment of primary hypercholesterolaemia
William Insull Jr, Adrian D Marais, Ronnie Aronson, Sheryl Manfreda, and the Fluvastatin Study Group
No content available
For healthcare professionals only
